Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia

NCT04779242 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

670

Enrollment

INDUSTRY

Sponsor class

Conditions

Community-acquired Pneumonia
Bacterial Pneumonia

Interventions

DRUG: Omadacycline
DRUG: Moxifloxacin

Sponsor

Paratek Pharmaceuticals Inc